Dashboard PDUFA PDUFA History Dilution Watch Downside Radar Missed Milestones Earnings Big Movers Blog

🎤 Upcoming Biotech Conferences

Loading conferences...
Free to browse, no account needed Follow the companies behind these drugs with free AI briefings, catalyst countdowns and dilution alerts.

Gorilla-derived Adenovirus-expressing HPV-16/18 E6/E7 Vaccine · PRGN-2009

Vaccine (Adenoviral vector) · Immune activation, directed at HPV-16/18 E6 protein and HPV-16/18 E7 protein · developed by Precigen

Phase 2 Most advanced trial
PGEN Developer
1 Registered trials

What is Gorilla-derived Adenovirus-expressing HPV-16/18 E6/E7 Vaccine?

PRGN-2009 is a gorilla-derived adenovirus vaccine expressing HPV-16 and HPV-18 E6 and E7 antigens, given subcutaneously. It is studied in combination with pembrolizumab in cervical cancer and other HPV-related malignancies.

Summary written with AI from the sources listed at the end of this page.

At a glance

Also known as
PRGN-2009
Drug type
Vaccine (Adenoviral vector)
Targets
HPV-16/18 E6 protein (antigen), HPV-16/18 E7 protein (antigen)
Mechanism
Immune activation, directed at HPV-16/18 E6 protein and HPV-16/18 E7 protein
Therapy area
Oncology
Developer
Precigen, Inc (PGEN)
FDA status
Investigational, not approved in the US. Most advanced trial: Phase 2

🧪 Clinical trials

TrialPhaseConditionStatusSponsor
NCT06157151 Phase 2 Cervical Cancer Recruiting PGEN

Trials of the companies BioRadar tracks, from ClinicalTrials.gov, most advanced phase first.

Conditions studied

Cervical CancerHPV-Related CarcinomaHPV-Related MalignancyMetastatic Cervical CancerRecurrent Cervical Carcinoma

More from Precigen

Sources

Updated Oct 25, 2026. Something wrong or missing? Report it on the PGEN page.

Follow PGEN, the company behind Gorilla-derived Adenovirus-expressing HPV-16/18 E6/E7 Vaccine

See PGEN's upcoming FDA decisions, trial readouts, cash runway and dilution risk, updated every day from SEC, FDA and ClinicalTrials.gov filings.

PGEN catalysts and pipeline →
Data: FDA (Drugs@FDA, Purple Book, DailyMed), NIH (NCI Thesaurus, GSRS, RxNorm), ClinicalTrials.gov • Informational purposes only, not medical or investment advice. • All drugs A–Z

This data is for informational purposes only, not investment advice. BioRadar does not provide buy/sell recommendations. Past performance does not guarantee future results. Always do your own due diligence.